Xen Primary Needling

Show Description +

Properly freeing the device from Tenon’s at the time of placement can potentially reduce postoperative needling rates for the Xen Gel Stent (Allergan).

Posted: 2/28/2023

Xen Primary Needling

Properly freeing the device from Tenon’s at the time of placement can potentially reduce postoperative needling rates for the Xen Gel Stent (Allergan).

Posted: 2/28/2023

Please log in to leave a comment.

More in Glaucoma

Academy IRIS® Registry Data Outcomes on Gel Stent Use

Arsham Sheybani, MD

Angle-Based MIGS for a Patient With Severe Glaucoma

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO

When a Minimally Invasive Procedure Fails

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Rachel G. Simpson, MD

Innovations in Glaucoma: The FYSX OPAP Device

I. Paul Singh, MD; and John P. Berdahl, MD